Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer

Tekijä Bello Roufai, Diana, Bidard, François-Clément
Julkaisussa Ann Transl Med (2019)

Circulating tumor cells in breast cancer

Tekijä Bidard, Francois-Clement, Proudhon, Charlotte, Pierga, Jean-Yves
Julkaisussa Mol Oncol (2016)

A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

Tekijä Bidard, François-Clément, Pierga, Jean-Yves, Vincent-Salomon, Anne, Poupon, Marie-France
Julkaistu 2008

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer

Tekijä Carausu, Marcela, Melaabi, Samia, Pierga, Jean-Yves, Bidard, François-Clément, Cabel, Luc
Julkaisussa J Breast Cancer (2019)

Clinical utility of circulating tumor cells: an update

Tekijä Vasseur, Antoine, Kiavue, Nicolas, Bidard, François‐Clément, Pierga, Jean‐Yves, Cabel, Luc
Julkaisussa Mol Oncol (2020)

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer

Tekijä Tanguy, Marie-Laure, Cabel, Luc, Berger, Fréderique, Pierga, Jean-Yves, Savignoni, Alexia, Bidard, Francois-Clement
Julkaisussa NPJ Breast Cancer (2018)

Circulating Tumor Cells in Early Breast Cancer

Tekijä Thery, Laura, Meddis, Alessandra, Cabel, Luc, Proudhon, Charlotte, Latouche, Aurelien, Pierga, Jean-Yves, Bidard, Francois-Clement
Julkaisussa JNCI Cancer Spectr (2019)

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer

Tekijä Nanou, Afroditi, Zeune, Leonie Laura, Bidard, Francois-Clement, Pierga, Jean-Yves, Terstappen, Leonardus Wendelinus Mathias Marie
Julkaisussa Breast Cancer Res (2020)

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Tekijä Decraene, Charles, Bortolini Silveira, Amanda, Michel, Marc, Bidard, François-Clément, Pierga, Jean-Yves, Stern, Marc-Henri, Proudhon, Charlotte
Julkaisussa J Vis Exp (2018)

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Tekijä Carausu, Marcela, Beddok, Arnaud, Langer, Adriana, Girard, Nicolas, Bidard, François-Clément, Massiani, Marie-Ange, Ricard, Damien, Cabel, Luc
Julkaisussa J Immunother Cancer (2019)

Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery

Tekijä Planeix, François, Siraj, Mohammad-Ahsan, Bidard, François-Clément, Robin, Blaise, Pichon, Christophe, Sastre-Garau, Xavier, Antoine, Martine, Ghinea, Nicolae
Julkaisussa J Exp Clin Cancer Res (2015)

Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance

Tekijä Ng, Charlotte K. Y., Weigelt, Britta, A’Hern, Roger, Bidard, Francois-Clement, Lemetre, Christophe, Swanton, Charles, Shen, Ronglai, Reis-Filho, Jorge S.
Julkaistu 2014

Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein

Tekijä Héquet, Delphine, Rodrigues, Manuel, Tardivon, Anne, Langer, Adriana, Dahan, Meryl, Rouzier, Roman, Takanen, Silvia, Kirova, Yulia, Bidard, François-Clément, Cottu, Paul
Julkaisussa Bull Cancer (2020)

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVAS...

Tekijä Sabatier, Renaud, Pierga, Jean-Yves, Curé, Hervé, Abulnaja, Rakan, Lambaudie, Eric, Bidard, François-Clément, Extra, Jean-Marc, Sfumato, Patrick, Gonçalves, Anthony
Julkaisussa Cancers (Basel) (2021)

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients

Tekijä Giordano, Antonio, Egleston, Brian L., Hajage, David, Bland, Joseph, Hortobagyi, Gabriel N., Reuben, James M., Pierga, Jean-Yves, Cristofanilli, Massimo, Bidard, Francois-Clement
Julkaistu 2013

A DNA methylation-based liquid biopsy for triple-negative breast cancer

Tekijä Cristall, Katrina, Bidard, Francois-Clement, Pierga, Jean-Yves, Rauh, Michael J., Popova, Tatiana, Sebbag, Clara, Lantz, Olivier, Stern, Marc-Henri, Mueller, Christopher R.
Julkaisussa NPJ Precis Oncol (2021)

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Tekijä Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Julkaistu 2012

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

Tekijä Bidard, François-Clément, Belin, Lisa, Delaloge, Suzette, Lerebours, Florence, Ngo, Charlotte, Reyal, Fabien, Alran, Séverine, Giacchetti, Sylvie, Marty, Michel, Lebofsky, Ronald, Pierga, Jean-Yves
Julkaistu 2013

A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging

Tekijä Mottet, Guillaume, Perez-Toralla, Karla, Tulukcuoglu, Ezgi, Bidard, Francois-Clement, Pierga, Jean-Yves, Draskovic, Irena, Londono-Vallejo, Arturo, Descroix, Stephanie, Malaquin, Laurent, Louis Viovy, Jean
Julkaistu 2014

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

Tekijä Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Julkaisussa Br J Cancer (2017)